Toshiaki Oka

Detailed analysis of anti‐emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia A

Y. Yoshimura, T. Soeda, M. Kaneda, 2021, Journal of thrombosis and haemostasis : JTH.

Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2)

J. Takamatsu, S. Ohga, Masao Kobayashi, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Study on the Causes, Types, and Mechanisms of Childhood Injuries-Age and Disease Specificity

Y. Nishida, S. Harada, N. Hosoda, 2021, JMA journal.